menu
    • menu

    Company profile for Vertex Pharmaceuticals

    NEW Drugs in Dev: 48
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Vertex, we have some of the industry's best and brightest people helping us achieve our mission of discovering transformative medicines to help people with serious diseases like cystic fibrosis. Whether they are in the lab, part of our business development team or on the phones with patients, we depend on a talented global workforce to lead the charge as we work toward developing tomorrow's breakthrough medicines.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Vertex PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    50 Northern Avenue Boston, MA 02210
    Telephone
    Telephone
    +1(617)-341-6100
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.vrtx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/vertex-pharmaceuticals
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    International Sweetener Colloquium

    Not Confirmed

    envelop Contact Supplier

    International Sweetener Colloquium

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vertex To Present At TD Cowen 46th Annual Health Care Conference
    Vertex To Present At TD Cowen 46th Annual Health Care Conference

    17 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260217188901/en/Vertex-to-Participate-in-TD-Cowen-46th-Annual-Health-Care-Conference-on-March-3

    BUSINESSWIRE
    17 Feb 2026
    Share Share
    Vertex Sets Lofty $500M Revenue Goal For New Products In '26
    Vertex Sets Lofty $500M Revenue Goal For New Products In '26

    13 Feb 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/casgevy-journavx-launches-pick-vertex-sets-ambitious-500m-revenue-goal-new-products-26

    FIERCE PHARMA
    13 Feb 2026
    Share Share
    Vertex's Journavx Painkiller Surpasses 500K Prescriptions
    Vertex's Journavx Painkiller Surpasses 500K Prescriptions

    13 Feb 2026

    // BIOSPACE

    https://www.biospace.com/business/all-eyes-on-vertexs-kidney-franchise-as-painkiller-journavx-tops-half-a-million-scripts

    BIOSPACE
    13 Feb 2026
    Share Share
    Vertex Releases 2025 Q4 And Full-Year Financial Results
    Vertex Releases 2025 Q4 And Full-Year Financial Results

    12 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260212596146/en/Vertex-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results

    BUSINESSWIRE
    12 Feb 2026
    Share Share
    Vertex to Announce Q4, Full-Year 2025 Results on Feb. 12
    Vertex to Announce Q4, Full-Year 2025 Results on Feb. 12

    20 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260120813466/en/Vertex-to-Announce-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-February-12th

    BUSINESSWIRE
    20 Jan 2026
    Share Share
    Vertex Pharma Updates Pipeline, Business Before Investor Day
    Vertex Pharma Updates Pipeline, Business Before Investor Day

    11 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260111805110/en/Vertex-Provides-Pipeline-and-Business-Updates-in-Advance-of-Upcoming-Investor-Meetings

    BUSINESSWIRE
    11 Jan 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search